Novel Antimalarial Drugs Through Epigenetics- Dr Matthew Fuchter

Add bookmark

Novel Antimalarial Drugs Through Epigenetics- Dr Matthew Fuchter

Add bookmark

Malaria is one of the world's largest public health problems and treatments for the disease still leave a lot to be desired. Dr Matthew Fuchter and his team have taken a novel approach to malaria treatment, focusing on the importance of epigenetic mechanisms in the malaria parasite. In this podcast, hear about the development of this new potential treatment.

eventpdf]

Have Your Say
Rate this feature and give us your feedback in the comments section below

Upcoming Events

Pharma Contract Manufacturing

23 - 25 March 2026

Mercure Hotel MOA Berlin, Germany

Pharma Contract Manufacturing

SmartLab Exchange USA

April 21 - 22, 2026

Philadelphia, USA

SmartLab Exchange USA

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended